These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17415363)

  • 1. Aggressive drug marketing tactics trigger backlash.
    Singer E
    Nat Med; 2007 Apr; 13(4):393. PubMed ID: 17415363
    [No Abstract]   [Full Text] [Related]  

  • 2. The physician and the pharmaceutical industry: both must keep the patient's interests at heart.
    Ravindran GD
    Issues Med Ethics; 1999; 7(1):21-2. PubMed ID: 16320467
    [No Abstract]   [Full Text] [Related]  

  • 3. Doctor, do you have a minute? The dilemma posed by physician interaction with the pharmaceutical industry.
    Quan SF
    J Clin Sleep Med; 2007 Jun; 3(4):345-6. PubMed ID: 17694720
    [No Abstract]   [Full Text] [Related]  

  • 4. A change in the market--investing in diagnostics.
    Batchelder K; Miller P
    Nat Biotechnol; 2006 Aug; 24(8):922-6. PubMed ID: 16900131
    [No Abstract]   [Full Text] [Related]  

  • 5. To sell their drugs, companies increasingly rely on doctors.
    Hensley S; Martinez B
    Wall St J (East Ed); 2005 Jul; ():A1,A2. PubMed ID: 16134281
    [No Abstract]   [Full Text] [Related]  

  • 6. Deconstructing Myogen's market cap.
    Ransom J
    Nat Biotechnol; 2006 Mar; 24(3):227-8. PubMed ID: 16525363
    [No Abstract]   [Full Text] [Related]  

  • 7. Conflict of interest in the physician interface with the biomedical industry.
    Minnigan H; Chisholm CD
    Emerg Med Clin North Am; 2006 Aug; 24(3):671-85. PubMed ID: 16877136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The devil is in the details: the pharmaceutical industry's use of gifts to physicians as marketing strategy.
    McFadden DW; Calvario E; Graves C
    J Surg Res; 2007 Jun; 140(1):1-5. PubMed ID: 17481979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Readers' and author's responses to "Physicians for sale: how medical professional organizations exploit their members".
    Adler AC
    Medscape J Med; 2008; 10(10):233; author reply 233. PubMed ID: 19117082
    [No Abstract]   [Full Text] [Related]  

  • 10. Readers' and author's responses to "Physicians for sale: how medical professional organizations exploit their members".
    Coli R
    Medscape J Med; 2008; 10(10):233; author reply 233. PubMed ID: 19117081
    [No Abstract]   [Full Text] [Related]  

  • 11. Biotech drug market steadily expands.
    Lawrence S
    Nat Biotechnol; 2005 Dec; 23(12):1466. PubMed ID: 16333279
    [No Abstract]   [Full Text] [Related]  

  • 12. Recombinant protein therapeutics--success rates, market trends and values to 2010.
    Pavlou AK; Reichert JM
    Nat Biotechnol; 2004 Dec; 22(12):1513-9. PubMed ID: 15583654
    [No Abstract]   [Full Text] [Related]  

  • 13. The pharmaceutical industry and the medical profession.
    Phatak A
    Issues Med Ethics; 1998; 6(4):131-2. PubMed ID: 16267942
    [No Abstract]   [Full Text] [Related]  

  • 14. Using drug samples can hinder quality.
    Healthcare Benchmarks Qual Improv; 2004 Mar; 11(3):34-5. PubMed ID: 15002360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A quiz on "the ethics of accepting gifts from industry".
    Holm RP;
    S D Med; 2007 Mar; 60(3):117-8. PubMed ID: 17455581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence and drug marketing.
    Sauri M
    Md Med; 2005; 6(1):24-5. PubMed ID: 15869104
    [No Abstract]   [Full Text] [Related]  

  • 17. Closing the sample closet.
    Sanders J
    Fam Pract Manag; 2006; 13(10):16, 21; author reply 21. PubMed ID: 17144005
    [No Abstract]   [Full Text] [Related]  

  • 18. Strong medicine for doctors: 'Just say no' to gifts from drug reps, a Columbia U. physician urges his colleagues.
    Mangan KS
    Chron High Educ; 2004 Jan; 50(18):A28-9. PubMed ID: 15287140
    [No Abstract]   [Full Text] [Related]  

  • 19. Beyond the naïve "no-see": ethical prescribing and the drive for pharmaceutical transparency.
    Oldani M
    PM R; 2009 Jan; 1(1):82-6. PubMed ID: 19627878
    [No Abstract]   [Full Text] [Related]  

  • 20. Physicians, pharmaceutical representatives, and patients: who really benefits?
    Westfall JM
    J Fam Pract; 2000 Sep; 49(9):817-9. PubMed ID: 11032206
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.